359 related articles for article (PubMed ID: 30048689)
1. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
Yan Q; Karau MJ; Raval YS; Patel R
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012765
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of oritavancin against biofilms of staphylococci isolated from prosthetic joint infection.
Yan Q; Karau MJ; Patel R
Diagn Microbiol Infect Dis; 2018 Oct; 92(2):155-157. PubMed ID: 29885758
[TBL] [Abstract][Full Text] [Related]
4. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
Richards GK; Morcos RJ; Gagnon RF
Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
[TBL] [Abstract][Full Text] [Related]
5. Prevention, inhibition, and degradation effects of melittin alone and in combination with vancomycin and rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis.
Mirzaei R; Alikhani MY; Arciola CR; Sedighi I; Yousefimashouf R; Bagheri KP
Biomed Pharmacother; 2022 Mar; 147():112670. PubMed ID: 35123230
[TBL] [Abstract][Full Text] [Related]
6. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
LaPlante KL; Woodmansee S
Antimicrob Agents Chemother; 2009 Sep; 53(9):3880-6. PubMed ID: 19564363
[TBL] [Abstract][Full Text] [Related]
7. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
J Antibiot (Tokyo); 2012 Oct; 65(10):505-8. PubMed ID: 22854340
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.
Fernández J; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369
[TBL] [Abstract][Full Text] [Related]
11. Virulence gene expression by Staphylococcus epidermidis biofilm cells exposed to antibiotics.
Gomes F; Teixeira P; Cerca N; Ceri H; Oliveira R
Microb Drug Resist; 2011 Jun; 17(2):191-6. PubMed ID: 21395450
[TBL] [Abstract][Full Text] [Related]
12. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
13. Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
Park KH; Greenwood-Quaintance KE; Schuetz AN; Mandrekar JN; Patel R
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855069
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs.
Reiter KC; Villa B; Paim TGDS; de Oliveira CF; d'Azevedo PA
J Med Microbiol; 2013 Mar; 62(Pt 3):394-399. PubMed ID: 23161766
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an
Jahanbakhsh S; Singh NB; Yim J; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784849
[TBL] [Abstract][Full Text] [Related]
16. Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms.
Peñalba Arias P; Furustrand Tafin U; Bétrisey B; Vogt S; Trampuz A; Borens O
Injury; 2015 Feb; 46(2):249-53. PubMed ID: 25498330
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.
Gomes F; Teixeira P; Ceri H; Oliveira R
Indian J Med Res; 2012 Apr; 135(4):542-7. PubMed ID: 22664505
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and biofilm formation of Staphylococcus epidermidis small colony variants associated with prosthetic joint infection.
Maduka-Ezeh AN; Greenwood-Quaintance KE; Karau MJ; Berbari EF; Osmon DR; Hanssen AD; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2012 Nov; 74(3):224-9. PubMed ID: 22901790
[TBL] [Abstract][Full Text] [Related]
19. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
Meléndez-Carmona MÁ; Muñoz-Gallego I; Viedma E; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2019 Sep; 54(3):356-360. PubMed ID: 31254616
[TBL] [Abstract][Full Text] [Related]
20. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
